COPD

FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease
Yahoo/Fly on the Wall
Fri, 05/10/13 - 12:31 pm
FDA
COPD
Breo Ellipta
Theravance
GSK,Theravance announce regulatory submission for Anoro Ellipta in Japan
Reuters
Mon, 04/22/13 - 11:13 am
Anoro Ellipta
Japan
COPD
GSK
Theravance
Glaxo-Theravance Lung Drug Gains Backing of FDA Advisers
Bloomberg
Wed, 04/17/13 - 04:34 pm
GSK
Breo Ellipta
FDA
COPD
Theravance
Mixed Messages on COPD Drug, FDA Review Finds
Med Page Today
Wed, 04/17/13 - 11:13 am
FDA
COPD
Breo Ellipta
GSK
Theravance
Almirall, Forest report positive results in inhaler trial
Reuters
Tue, 04/16/13 - 12:14 pm
Almirall
Forest Labs
COPD
Genuair
Data may support efficacy of COPD combo therapy, FDA document says
The Fly on the Wall
Mon, 04/15/13 - 08:46 am
FDA
COPD
GSK
Theravance
Breo Ellipta
4 Can't-Miss Health-Care Events This Week
Motley Fool
Mon, 03/4/13 - 10:46 am
Depomed
FDA
Serada
Breo Ellipta
COPD
GSK
Theravance
Aegerion
Sarepta
Boehringer Lung Drug Wins U.S. FDA Advisory Panel Backing
Bloomberg
Wed, 01/30/13 - 10:59 am
FDA
COPD
Boehringer Ingelheim
olodaterol
Boehringer’s Lung Drug’s Benefits Questioned
Bloomberg
Fri, 01/25/13 - 10:08 am
Boehringer Ingelheim
olodaterol
COPD
5 Drug Hopefuls That Are Going to Change Your Life: Part 5
Motley Fool
Fri, 12/21/12 - 10:54 am
LAMA/LABA
GSK
Theravance
COPD
Novartis COPD drug Seebri gets thumbs-up in Europe
Pharma Times, UK
Mon, 10/1/12 - 12:30 pm
Novartis
COPD
Europe
Seebri Breezhaler
FDA approves Forest Labs drug for lung disease
Yahoo/AP
Mon, 07/23/12 - 10:26 pm
FDA
Forest Labs
COPD
Tudorza Pressair
GSK and Theravance file next-generation Advair in USA, EU
Pharma Times, UK
Mon, 07/16/12 - 12:24 pm
Advair
GSK
Theravance
Breo
COPD
asthma
GSK hails positive results for combo new lung drug
Reuters
Mon, 07/2/12 - 10:46 am
GSK
Theravance
LAMA/LABA
COPD
Breathe Deeply: Safety Concerns Over Spiriva
Pharmalot
Thu, 05/24/12 - 10:15 am
Spiriva
Boehringer Ingelheim
COPD
GlaxoSmithKline's Q1 Call Has Muted Mention Of Relovair
Seeking Alpha
Sun, 04/29/12 - 12:32 pm
GSK
Relovair
asthma
COPD
FDA extends review period for Forest Lab lung drug
Reuters
Thu, 03/29/12 - 12:07 pm
COPD
Forest Labs
FDA
Almirall
GSK lung drug has mixed results but filing on track
Reuters
Fri, 03/23/12 - 12:22 pm
GSK
Relovair
COPD
Theravance
U.S. panel backs Forest Labs drug for smoker's cough
Reuters
Thu, 02/23/12 - 05:45 pm
Forest Labs
COPD
Almirall
aclidinium bromide
Theravance: A $1.5 Billion Company With An $8 Billion Product
Seeking Alpha
Wed, 02/22/12 - 05:47 pm
Theravance
GSK
Pfizer
Relovair
Advair
AstraZeneca
asthma
COPD

Pages